DE602004015425D1 - Pyridiniumsalze und deren verwendung - Google Patents

Pyridiniumsalze und deren verwendung

Info

Publication number
DE602004015425D1
DE602004015425D1 DE602004015425T DE602004015425T DE602004015425D1 DE 602004015425 D1 DE602004015425 D1 DE 602004015425D1 DE 602004015425 T DE602004015425 T DE 602004015425T DE 602004015425 T DE602004015425 T DE 602004015425T DE 602004015425 D1 DE602004015425 D1 DE 602004015425D1
Authority
DE
Germany
Prior art keywords
pyridinium salt
methods
conditions
prophylaxis
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004015425T
Other languages
English (en)
Inventor
Richard B Klein
Jeffrey L Selph
John J Partridge
John F Reinhard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mycosol Inc
Original Assignee
Mycosol Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mycosol Inc filed Critical Mycosol Inc
Publication of DE602004015425D1 publication Critical patent/DE602004015425D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
DE602004015425T 2003-03-03 2004-03-03 Pyridiniumsalze und deren verwendung Expired - Fee Related DE602004015425D1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US45059903P 2003-03-03 2003-03-03
US48099503P 2003-06-23 2003-06-23
US52478403P 2003-11-25 2003-11-25
US52477503P 2003-11-25 2003-11-25
US52507503P 2003-11-25 2003-11-25
PCT/US2004/006437 WO2004078136A2 (en) 2003-03-03 2004-03-03 Pyridinium salts, compounds and methods of use

Publications (1)

Publication Number Publication Date
DE602004015425D1 true DE602004015425D1 (de) 2008-09-11

Family

ID=32966824

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004015425T Expired - Fee Related DE602004015425D1 (de) 2003-03-03 2004-03-03 Pyridiniumsalze und deren verwendung

Country Status (11)

Country Link
US (5) US7220761B2 (de)
EP (1) EP1601652B1 (de)
JP (1) JP4742028B2 (de)
KR (1) KR20050108373A (de)
AT (1) ATE402924T1 (de)
AU (1) AU2004218452A1 (de)
BR (1) BRPI0407991A (de)
CA (1) CA2517461A1 (de)
DE (1) DE602004015425D1 (de)
MX (1) MXPA05009449A (de)
WO (1) WO2004078136A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2517461A1 (en) 2003-03-03 2004-09-16 Mycosol, Inc. Pyridinium salts, compounds and methods of use
SE527166C2 (sv) * 2003-08-21 2006-01-10 Kerttu Eriksson Förfarande och anordning för avfuktning
CA2590932A1 (en) * 2004-12-17 2006-06-22 Mycosol, Inc. Thiazolium compounds and uses thereof
WO2006089747A2 (en) * 2005-02-24 2006-08-31 Syngenta Participations Ag Presticidal capsule formulation
EP1875654A2 (de) * 2005-04-08 2008-01-09 Mycosol, Inc. Stilbazium-forschungstestvorrichtungen
US20080295582A1 (en) * 2005-06-21 2008-12-04 Peng Lee Nondestructive Residential Inspection Method
US8247571B2 (en) 2005-11-08 2012-08-21 Mycosol, Inc. Pyridinium and thiazolium conjugates including polyethylene glycols and methods of using the same
WO2007056340A2 (en) * 2005-11-08 2007-05-18 Mycosol, Inc. Disinfectant and antiseptic pyridinium and thiazolium compounds and methods of using the same
US20070227399A1 (en) * 2006-04-03 2007-10-04 Novus International Inc. Compositions and methods for the preservation of wood
JP2007277790A (ja) * 2006-04-07 2007-10-25 Jae Woo Yang 熱色性物質層を備えたウォールペーパー及びその製造方法
WO2008088917A2 (en) * 2007-01-19 2008-07-24 Mycosol, Inc. Methods of using pyridinium and thiazolium compounds as reagents, diagnostic compounds and therapeutic agents
WO2009112360A1 (en) * 2008-03-10 2009-09-17 Basf Se Encapsulated phase change materials in seed coatings
US9538762B2 (en) * 2009-12-31 2017-01-10 Building Materials Investment Corporation Antimicrobial delivery system for roof coverings
US9642829B2 (en) * 2012-12-04 2017-05-09 The University Of Hong Kong Antifungal compound and uses thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790E (fr) * 1903-09-22 1904-06-15 David Perret Dispositif moteur électrique à double coupe-circuit
BE616609A (fr) * 1961-04-24 1962-10-18 Wellcome Found Composés ammonium quaternaires, procédé pour les préparer et compositions pharmaceutiques les contenant
US3085935A (en) * 1961-04-24 1963-04-16 Burroughs Wellcome Co Method for the elimination of nematode infestations
NL277327A (de) * 1961-04-24
GB1018454A (en) * 1962-10-18 1966-01-26 Smith Kline French Lab Improvements in or relating to antibacterial and antifungal compositions
ES297752A1 (es) * 1963-03-22 1964-08-16 Wellcome Found Un metodo para la preparaciën de una nueva sal de un catiën de diestilbazol cuaternario
DE1200302B (de) * 1963-04-30 1965-09-09 Bayer Ag Verfahren zur Herstellung von Monosalzen bisquartaerer Pyridiniumverbindungen
US3883658A (en) * 1968-09-19 1975-05-13 Burroughs Wellcome Co Method of treating nematode infestations
US3867535A (en) 1971-12-01 1975-02-18 Ciba Geigy Corp Thiadiazolium salts as antihelmintic agents
US3934017A (en) 1971-12-07 1976-01-20 Ciba-Geigy Corporation Anthelmintic composition and method utilizing isothiocyanobenzazoles active ingredients
AR207744A1 (es) 1972-08-10 1976-10-29 Ciba Geigy Ag Procedimiento para la preparacion de nuevos derivados de isotiocianopiridinas
CA1022554A (en) 1973-03-07 1977-12-13 Haukur Kristinsson 1-carbamoyl-2-alkoxycarbonylaminoimidazo (4,5-b) pyridines
DK645374A (de) * 1974-01-22 1975-09-29 Ciba Geigy Ag
US4105793A (en) * 1976-07-28 1978-08-08 Celanese Corporation Multifunctional acrylates as foliar fungicides
US4153723A (en) 1977-01-10 1979-05-08 Ciba-Geigy Corporation Anthelmintic agents
NL7800191A (nl) 1977-01-10 1978-07-12 Ciba Geigy Anthelmintisch preparaat.
US4205077A (en) * 1977-04-12 1980-05-27 Ciba-Geigy Corporation Benzimidazole sulphides as anthelmintic agents
CH634306A5 (de) * 1977-04-12 1983-01-31 Ciba Geigy Ag Benzimidazolderivate, verfahren zu ihrer herstellung und anthelmintische mittel enthaltend diese verbindungen als wirkstoffe.
GB8323949D0 (en) 1983-09-07 1983-10-12 Wyeth John & Brother Ltd Pyridinium compounds
JP2941041B2 (ja) * 1990-11-16 1999-08-25 シスメックス株式会社 フローサイトメトリーによる白血球の分類方法
JP3070968B2 (ja) * 1991-05-14 2000-07-31 シスメックス株式会社 尿中の細胞分析用試薬及び方法
JPH09510739A (ja) 1995-03-20 1997-10-28 オリオン エレクトリック カンパニー リミティッド スチルバゾリウム塩、その製造方法及び使用
US20030138374A1 (en) * 2000-03-22 2003-07-24 Yukitsuda Kudo Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
WO2002061415A1 (en) * 2001-02-01 2002-08-08 Salafsky Joshua S Designs of labels for detection with a surface-selective nonlinear optical technique
CN1394854A (zh) * 2002-07-04 2003-02-05 华东师范大学 多取代吡啶盐类化合物及其制备方法
CA2517461A1 (en) * 2003-03-03 2004-09-16 Mycosol, Inc. Pyridinium salts, compounds and methods of use

Also Published As

Publication number Publication date
AU2004218452A1 (en) 2004-09-16
CA2517461A1 (en) 2004-09-16
JP2007525441A (ja) 2007-09-06
US20040224984A1 (en) 2004-11-11
US7547444B1 (en) 2009-06-16
US7820696B2 (en) 2010-10-26
WO2004078136A3 (en) 2004-12-16
US20090137639A1 (en) 2009-05-28
WO2004078136A2 (en) 2004-09-16
EP1601652A2 (de) 2005-12-07
US20040235898A1 (en) 2004-11-25
EP1601652B1 (de) 2008-07-30
ATE402924T1 (de) 2008-08-15
US20100267716A1 (en) 2010-10-21
MXPA05009449A (es) 2006-04-07
KR20050108373A (ko) 2005-11-16
US20070213299A1 (en) 2007-09-13
BRPI0407991A (pt) 2006-03-07
US7220761B2 (en) 2007-05-22
JP4742028B2 (ja) 2011-08-10
US8124626B2 (en) 2012-02-28

Similar Documents

Publication Publication Date Title
DE602004015425D1 (de) Pyridiniumsalze und deren verwendung
ATE432072T1 (de) Verwendung von adapalen zur behandlung dermatologischer erkrankungen
ATE325125T1 (de) Thienopyrrolyl und furanopyrrolyl verbindungen und deren verwendung als histamin h4 rezeptor liganden
CY1116754T1 (el) Παραγωγα νιτροκατεχολης ως αναστολεις της comt
MY140031A (en) Carbonyl compounds
NO20092639L (no) 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav
NZ542616A (en) P38 inhibitors and methods of use thereof
NO20081434L (no) 5-(fenylisoksazolyletoksy)-triazol-3-yl substituert pyridinsammensetninger for behandling av neurologisk, psykiatrisk eller smerteforstyrrelser
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
MY148375A (en) Delta and epsilon crystal forms of imatinib mesylate
NO20082096L (no) Azaindol-2-karboksamidderivativer
MY146403A (en) F, g, h, i and k crystal forms of imatinib mesylate
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
NO20050063L (no) 2-heteroaryl karboksamider
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
NO20055741D0 (no) Nye kjemiske forbindelser
ATE413392T1 (de) Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren
ATE336996T1 (de) Verwendung von flavonoid-derivaten zur behandlung von atopischem ekzem
ATE475651T1 (de) Aryl-substituierte heterozyklen und ihre verwendung
ATE433459T1 (de) Desoxo-nonadepsipeptide
ATE455789T1 (de) Substituierte nonadepsipeptide
ATE524463T1 (de) 4-chromenonyl-1,4-dihydropyridincarbonitrile und ihre verwendung
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
DK1971608T3 (da) Spiroketaler
ATE524488T1 (de) Lysobactinamide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee